Biovie股价在定价1200万美元公开发行后暴跌

英为财情
Aug 09, 2025

Investing.com -- Biovie Inc (NASDAQ:BIVI)股价暴跌43%,此前这家临床阶段生物制药公司宣布了1200万美元承销公开发行的定价。 此次发行包括600万个单位,每个单位定价为2.00美元,每个单位由一股普通股和一份权证组成。这些权证的行使价为每股2.50美元,将在发行后五年到期。该公司还提供预付费单位作为替代选择,每个单位由一份预付费权证和一份权证组成。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10